elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37274957-1D712A80-4DC7-4B48-AF86-9C9F9F35E7C3
Q37274957-1D712A80-4DC7-4B48-AF86-9C9F9F35E7C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37274957-1D712A80-4DC7-4B48-AF86-9C9F9F35E7C3
Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
P2860
Q37274957-1D712A80-4DC7-4B48-AF86-9C9F9F35E7C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37274957-1D712A80-4DC7-4B48-AF86-9C9F9F35E7C3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfac1eb8dd5f29721f557abd2a4fee15035eb841
P2860
Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.